Med Life (BSE:M) Other Long Term Assets: lei0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:M Med Life SA BSE:M
92 GF Score
Price lei10.24
GF Value lei8.11
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Med Life Other Long Term Assets?

Med Life BSE:M +0.79% 92 Other Long Term Assets is lei0 Mil as of Jun. 2026. GuruFocus rates BSE:M with a GF Score™ of 92/100 and a GF Value™ of lei8.11 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Med Life's other long-term assets for the quarter that ended in Jun. 2026 was lei0 Mil.

Med Life's quarterly other long-term assets declined from Dec. 2025 (lei116 Mil) to Mar. 2026 (lei0 Mil) but then stayed the same from Mar. 2026 (lei0 Mil) to Jun. 2026 (lei0 Mil).

Med Life's annual other long-term assets increased from Dec. 2023 (lei74 Mil) to Dec. 2024 (lei85 Mil) and increased from Dec. 2024 (lei85 Mil) to Dec. 2025 (lei116 Mil).

Med Life Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Med Life's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Med Life Other Long Term Assets Chart

Med Life Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.94 84.14 73.90 85.01 115.71

Med Life Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 115.71 0.00 0.00
BSE:M
92GF Score
Med Life SA BSE:M
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Life Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of lei0 Mil mean?
Med Life (BSE:M) has a Other Long Term Assets of lei0 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Med Life and its competitors.
Is Med Life's Other Long Term Assets too high?
Med Life's current Other Long Term Assets is lei0 Mil. Overall, Med Life has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's Other Long Term Assets compare to HCA and THC?
Med Life's Other Long Term Assets of lei0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Med Life and its competitors. Med Life's current Other Long Term Assets is lei0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (BSE:M) is currently considered Modestly Overvalued. The stock's GF Value™ is lei8.11, compared to a current price of lei10.24 — trading 26.3% above its estimated fair value. The current Other Long Term Assets is lei0 Mil. Med Life's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Med Life (BSE:M), the current Other Long Term Assets is lei0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Med Life (BSE:M) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei10.24 is trading 26.3% above its estimated GF Value™ of lei8.11. GuruFocus considers Med Life to be Modestly Overvalued.

Key valuation signals for BSE:M:

  • Other Long Term Assets: lei0 Mil
  • GF Value™: lei8.11 vs. price of lei10.24 (26.3% above fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the BSE:M stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Med Life Business Description

Other Exchanges 0RO5:UKO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
92GF Score

Get the complete analysis for BSE:M

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei10.24
Price
lei8.11
GF Value